Open Access

LINC00210 plays oncogenic roles in non‑small cell lung cancer by sponging microRNA‑328‑5p

  • Authors:
    • Zhengjia Liu
    • Lei Xu
    • Kejian Zhang
    • Bo Guo
    • Zhi Cui
    • Nan Gao
  • View Affiliations

  • Published online on: March 11, 2020     https://doi.org/10.3892/etm.2020.8593
  • Pages: 3325-3331
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Long noncoding RNA (lncRNA) has an important role in regulating non‑small cell lung cancer (NSCLC) progression. The present study aimed to investigate the effect of LINC00210 in NSCLC progression in order to provide a novel treatment target for patients with NSCLC. A total of 39 NSCLC patients were obtained and divided into LINC00210 high expression and low expression groups. Subsequently, the 5‑year survival rate from this patient cohort was analyzed. The SK‑MES‑1 and A549 NSCLC and the human 16‑HBE bronchial epithelial cell lines were utilized to investigate expression level of LIN00210. A549 cells were used to investigate cell proliferation, migration and invasive abilities using Cell Counting kit 8, Transwell and Matrigel assays, respectively. In addition, the luciferase reporter gene assay was performed to investigate the potential target of LINC00210. Reverse transcription‑quantitative PCR was used to determine LINC00210 and microRNA (miR)‑328‑5p expression levels in NSCLC tissues and tumor cell lines (SK‑MES‑1 and A549). The results demonstrated that LINC00210 was upregulated in NSCLC tissues and cell lines compared with that in normal tissues and 16‑HBE cells, and that LINC00210 expression was associated with a poor prognosis in patients with NSCLC (P<0.05). Furthermore, A549 cell transfection with small interfering (si)LINC00210#1 and siLINC00210#2 induced a significant decrease in cell proliferation, and migratory and invasive abilities compared with that in the control groups (P<0.05). In addition, miR‑328‑5p overexpression was stimulated by knockdown of LINC00210. Furthermore, A549 cells transfected with siLINC00210#1 and miR‑328‑5p inhibitor exhibited a significant increase in cell proliferation, and migratory and invasive ability compared with that in A549 cells transfected with siLINC00210#1. These findings suggest that LINC00210 may serve as an oncogenic role in NSCLC by sponging miR‑328‑5p.

Related Articles

Journal Cover

May 2020
Volume 19 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Liu, Z., Xu, L., Zhang, K., Guo, B., Cui, Z., & Gao, N. (2020). LINC00210 plays oncogenic roles in non‑small cell lung cancer by sponging microRNA‑328‑5p. Experimental and Therapeutic Medicine, 19, 3325-3331. https://doi.org/10.3892/etm.2020.8593
MLA
Liu, Z., Xu, L., Zhang, K., Guo, B., Cui, Z., Gao, N."LINC00210 plays oncogenic roles in non‑small cell lung cancer by sponging microRNA‑328‑5p". Experimental and Therapeutic Medicine 19.5 (2020): 3325-3331.
Chicago
Liu, Z., Xu, L., Zhang, K., Guo, B., Cui, Z., Gao, N."LINC00210 plays oncogenic roles in non‑small cell lung cancer by sponging microRNA‑328‑5p". Experimental and Therapeutic Medicine 19, no. 5 (2020): 3325-3331. https://doi.org/10.3892/etm.2020.8593